Page last updated: 2024-12-06

5-ethyluracil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

5-ethyluracil: antagonist of dihydrouracil dehydrogenase (NADP) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73267
SCHEMBL ID161148
SCHEMBL ID14048734
MeSH IDM0138379

Synonyms (30)

Synonym
AC-1385
2,4(1h,3h)-pyrimidinedione, 5-ethyl-
5-ethyl-1h-pyrimidine-2,4-dione
5-ethyluracil
4212-49-1
2,4-dihydroxy-5-ethylpyrimidine
E0807
5-ethyl uracil
A825775
AKOS005206784
FT-0610119
5-ethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
SCHEMBL161148
mfcd00079187
SY002972
uracil, 5-ethyl-
1,2,3,4-tetrahydropyrimidine, 5-ethyl-2,4-dioxo-
5-ethyl-2,4-pyrimidinediol #
W-202727
SCHEMBL14048734
DTXSID60194959
GS-3069
5-ethyl-2,4(1h,3h)-pyrimidinedione
5-ethylpyrimidine-2,4(1h,3h)-dione
CS-B1504
AMY23293
H10158
2,4-dihydroxy-5-ethylpyrimidine, homothymine
SB57227
EN300-95986

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" At each dosage level, semilogarithmic plots of concentration vs."( Elimination of the antiviral drug 5-ethyl-2'-deoxyuridine by the isolated perfused rat liver.
Joly, JM; Williams, WM,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (33.33)18.7374
1990's6 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]